In our study the Bladder Cancer Molecular Taxonomy Group collaborated to extend a first consensus report, addressing the need for a consensus molecular classification for muscle-invasive bladder cancer (MIBC) that would support basic research and clinical trials. We provide such a consensus classification and offer a single-sample classifier (http://cit.ligue-cancer.net:3838/apps/consensusMIBC_web)
We sought to define the prevalence and co-occurrence of actionable genomic alterations in patients w...
Context Recent whole genome mRNA expression profiling studies revealed that bladder cancers can be g...
Bladder cancer incurs a higher lifetime treatment cost than other cancers due to frequent recurrence...
BACKGROUND Muscle-invasive bladder cancer (MIBC) is a molecularly diverse disease with heterogene...
Bladder Cancer is the 4th most commonly diagnosed cancer in men and the 8th most deadly. While non-m...
Data de publicació electrònica: 26-09-2019Background: Muscle-invasive bladder cancer (MIBC) is a mol...
Bladder cancer is a heterogeneous disease that is not depicted by current classification systems. It...
Therapeutic decisions for muscle-invasive bladder cancer (MIBC) are largely based on histopathologic...
We report a comprehensive analysis of 412 muscle-invasive bladder cancers characterized by multiple ...
Background: Muscle-invasive bladder cancer (MIBC) is a molecularly diverse disease with heterogeneou...
AbstractContextRecent whole genome mRNA expression profiling studies revealed that bladder cancers c...
Bladder cancer is a biologically and clinically heterogeneous disease. Traditional classification sy...
Background: It has been suggested that bladder cancer can be divided into two molecular subtypes ref...
CONTEXT: Recent whole genome mRNA expression profiling studies revealed that bladder cancers can be ...
Context: Recent whole genome mRNA expression profiling studies revealed that bladder cancers can be ...
We sought to define the prevalence and co-occurrence of actionable genomic alterations in patients w...
Context Recent whole genome mRNA expression profiling studies revealed that bladder cancers can be g...
Bladder cancer incurs a higher lifetime treatment cost than other cancers due to frequent recurrence...
BACKGROUND Muscle-invasive bladder cancer (MIBC) is a molecularly diverse disease with heterogene...
Bladder Cancer is the 4th most commonly diagnosed cancer in men and the 8th most deadly. While non-m...
Data de publicació electrònica: 26-09-2019Background: Muscle-invasive bladder cancer (MIBC) is a mol...
Bladder cancer is a heterogeneous disease that is not depicted by current classification systems. It...
Therapeutic decisions for muscle-invasive bladder cancer (MIBC) are largely based on histopathologic...
We report a comprehensive analysis of 412 muscle-invasive bladder cancers characterized by multiple ...
Background: Muscle-invasive bladder cancer (MIBC) is a molecularly diverse disease with heterogeneou...
AbstractContextRecent whole genome mRNA expression profiling studies revealed that bladder cancers c...
Bladder cancer is a biologically and clinically heterogeneous disease. Traditional classification sy...
Background: It has been suggested that bladder cancer can be divided into two molecular subtypes ref...
CONTEXT: Recent whole genome mRNA expression profiling studies revealed that bladder cancers can be ...
Context: Recent whole genome mRNA expression profiling studies revealed that bladder cancers can be ...
We sought to define the prevalence and co-occurrence of actionable genomic alterations in patients w...
Context Recent whole genome mRNA expression profiling studies revealed that bladder cancers can be g...
Bladder cancer incurs a higher lifetime treatment cost than other cancers due to frequent recurrence...